Fewer researchers resorting to aborted baby cells

A pro-life outreach organization finds it interesting that a particular research company is now refusing to use aborted baby cell lines for vaccine research.

The rush for a COVID-19 vaccine has been on for several months now, as the pandemic has wracked nations throughout the world. Between 70 and 100 operations are doing the research, some using cell lines from aborted babies.

"I've researched 30 of them so far, and the majority of the 30 are doing it morally," reports Debi Vinnedge of Children of God for Life. "But there are some using aborted fetal cells, and we do have that list on our website."

Astrozeneca recently stopped human trials of its vaccine using the cells because of the harm it caused a patient. And Vinnedge notes that Sanofi Pasteur, which recently stopped using the cells for its polio vaccines, bought a company called Protein Sciences about three years ago.

"They inherited their platform that they were using from manufacturing flu vaccines, which is insect cells," she tells OneNewsNow. "It's interesting now, because now moving forward, Sanofi Pasteur has teamed up with GlaxoSmithKline for COVID, and they're actually producing a moral COVID vaccine using those insect cell lines."

Oxford, Johnson & Johnson, and the University of Pittsburgh are among those continuing to use cell lines from aborted babies in their research.